La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
VIVO Aperçu des actions
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide.
Score flocon de neige | |
---|---|
Évaluation | 4/6 |
Croissance future | 0/6 |
Performances passées | 1/6 |
Santé financière | 6/6 |
Dividendes | 0/6 |
Meridian Bioscience, Inc. Concurrents
Historique des prix et performances
Historique des cours de bourse | |
---|---|
Prix actuel de l'action | US$33.97 |
Plus haut sur 52 semaines | US$34.38 |
Plus bas sur 52 semaines | US$21.09 |
Bêta | 0.23 |
1Variation sur 1 mois | 2.29% |
Variation sur 3 mois | 6.02% |
Variation sur 1 an | 54.34% |
3Variation sur 3 ans | 295.23% |
Variation sur 5 ans | 128.75% |
Évolution depuis l'introduction en bourse | 6,030.20% |
Nouvelles et mises à jour récentes
Recent updates
Meridian Bioscience Non-GAAP EPS of $0.16 misses by $0.01, revenue of $67.8M beats by $1M
Aug 05Meridian Bioscience: High-Probability Merger Arbitrage
Jul 26Meridian Bioscience downgraded at William Blair on $1.53B acquisition
Jul 07Meridian Bioscience (NASDAQ:VIVO) Has A Pretty Healthy Balance Sheet
Jun 27Meridian Bioscience: Correctly Valued
Jun 26Many Would Be Envious Of Meridian Bioscience's (NASDAQ:VIVO) Excellent Returns On Capital
Jun 09Meridian Bioscience: Deceptively Priced
Mar 14Meridian Bioscience (NASDAQ:VIVO) Looks To Prolong Its Impressive Returns
Feb 03These 4 Measures Indicate That Meridian Bioscience (NASDAQ:VIVO) Is Using Debt Safely
Jul 19If The COVID-19 Delta Variant Spreads This Fall, Meridian Is Still A Buy
Jul 08Meridian Bioscience (NASDAQ:VIVO) Might Become A Compounding Machine
May 10Meridian Bioscience, Inc. 2021 Q2 - Results - Earnings Call Presentation
May 08Meridian Bioscience (NASDAQ:VIVO) Seems To Use Debt Rather Sparingly
Mar 31Have Insiders Been Buying Meridian Bioscience, Inc. (NASDAQ:VIVO) Shares?
Mar 11Investors Who Bought Meridian Bioscience (NASDAQ:VIVO) Shares A Year Ago Are Now Up 185%
Feb 24Need To Know: Analysts Are Much More Bullish On Meridian Bioscience, Inc. (NASDAQ:VIVO) Revenues
Feb 09Meridian expands production capacity for COVID-19 tests with NIH funding
Feb 03Should We Be Excited About The Trends Of Returns At Meridian Bioscience (NASDAQ:VIVO)?
Jan 27Rendement pour les actionnaires
VIVO | US Medical Equipment | US Marché | |
---|---|---|---|
7D | 0.06% | 3.9% | 4.9% |
1Y | 54.3% | 11.2% | 25.6% |
Rendement vs Industrie: VIVO exceeded the US Medical Equipment industry which returned -3.3% over the past year.
Rendement vs marché: VIVO exceeded the US Market which returned 14.1% over the past year.
Volatilité des prix
VIVO volatility | |
---|---|
VIVO Average Weekly Movement | 2.3% |
Medical Equipment Industry Average Movement | 8.3% |
Market Average Movement | 6.3% |
10% most volatile stocks in US Market | 15.0% |
10% least volatile stocks in US Market | 3.2% |
Cours de l'action stable: VIVO has not had significant price volatility in the past 3 months.
Volatilité au fil du temps: VIVO's weekly volatility (2%) has been stable over the past year.
À propos de l'entreprise
Fondée | Salariés | PDG | Site web |
---|---|---|---|
1976 | 704 | Jack Kenny | www.meridianbioscience.com |
Meridian Bioscience, Inc. Résumé des fondamentaux
VIVO statistiques fondamentales | |
---|---|
Capitalisation boursière | US$1.49b |
Bénéfices(TTM) | US$42.46m |
Recettes(TTM) | US$333.02m |
35.2x
Ratio P/E4.5x
Ratio P/SLe site VIVO est-il surévalué ?
Voir Juste valeur et analyse de l'évaluationBénéfices et recettes
VIVO compte de résultat (TTM) | |
---|---|
Recettes | US$333.02m |
Coût des recettes | US$144.66m |
Marge brute | US$188.36m |
Autres dépenses | US$145.90m |
Les revenus | US$42.46m |
Derniers bénéfices déclarés
Sep 30, 2022
Prochaine date de publication des résultats
s/o
Résultat par action (EPS) | 0.96 |
Marge brute | 56.56% |
Marge bénéficiaire nette | 12.75% |
Ratio dettes/capitaux propres | 6.8% |
Quelles ont été les performances à long terme de VIVO?
Voir les performances historiques et les comparaisons